• Ticker

DJIA 12,454.83 -74.92 -0.60%
NASDAQ 2,837.53 -1.85 -0.07%
S&P 500 1,317.82 -2.86 -0.22%

Volcano

NASDAQ:VOLC

$28.69 -$0.20 (-0.69%)

REAL-TIME: Last trade at

Volcano Corporation Presentation At Jefferies Conference To Be Webcast

Volcano's Proprietary iFRĀ® Functionality Demonstrates Excellent Results in Presentations at EuroPCR 2012

Leerink's medical supplies and devices analysts hold a conference call

Volcano to Highlight its Leadership in Precision Guided Therapy at EuroPCR 2012

Volcano Corp. Misses by a Penny - Analyst Blog

Volcano Corp. Misses by a Penny

Canaccord Genuity Maintains a 'Hold' on Volcano Corp. (VOLC); Get Constructive on Weakness

Volcano shares should be bought on any weakness, says Roth Capital

Onyx Pharmaceuticals downgraded to Buy from Conviction Buy at Goldman

Volcano Corp. (VOLC) Misses Q1 EPS by 1c

Volcano reaffirms 2012 revenue outlook $392M-$399M, consensus $395.74M

Volcano reports Q1 EPS 0c, consensus 1c

Volcano Corporation Schedules First Quarter Conference Call, Webcast

Piper Jaffray's medtech research team holds a conference call

Jefferies Upgrades Volcano Corp. (VOLC) to Buy

Volcano upgraded to Buy from Hold at Jefferies

Volcano management to meet with Leerink

Leerink hosts a medical and supplies dinner meeting

Volcano management to meet with Jefferies

Volcano upgraded to Buy from Neutral at Goldman

Goldman Sachs Upgrades Volcano Corp. (VOLC) to Buy

Volcano Corporation Presentation at Roth Conference to be Webcast

Volcano initiated with a Market Perform at Northland Securities

Jefferies Maintains a 'Hold' on Volcano Corp. (VOLC); Concerns with IVUS

Volcano gaps below its 10-day MA, support is at $27.57, then $26.94

Volcano downgraded to Buy from Strong Buy at Feltl

Volcano sees FY12 EPS 21c-24c, consensus 30c

Volcano reports Q4 adjusted EPS 14c, consensus 5c

Volcano Corp. (VOLC) Tops Q4 EPS by 9c; Guides FY12 EPS Below Expectations

Volcano Reports 14 Percent Increase in Fourth Quarter Revenues; Medical Segment Revenues Grow 20 Percent

Volcano Corporation Schedules Fourth Quarter Conference Call, Webcast

Piper Jaffray's medtech research team holds a conference call

Canaccord Genuity Maintains a 'Hold' on Volcano Corp (VOLC); Q4 Sales Miss Is A First

Volcano Corp. (VOLC) Sees Q4 Revs Below Views; FY11 Sightly Light

Volcano reports preliminary Q4 revenue $92.7M vs. consensus $93.1M

Volcano Corporation Announces Preliminary Fourth Quarter 2011 Revenues

BMO Capital Downgrades Volcano Corp. (VOLC) to Market Perform

Volcano downgraded to Market Perform from Outperform at BMO Capital

Feltl's 2012 Top Idea List

Volcano Corporation Presentation at J.P. Morgan Conference to be Webcast

See More Articles...